Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
A-form double-stranded RNA (dsRNA) is the primary structural conformation of duplex RNA, characterized by a deep, narrow major groove and a shallow, wide minor groove [12, 16]. It serves as a critical Pathogen-Associated Molecular Pattern (PAMP) that signals the presence of viral infection to the host's innate immune system [5, 9]. Recognition of A-form dsRNA by pattern recognition receptors (PRRs) such as Toll-like receptor 3 (TLR3), RIG-I, and MDA5 triggers the production of Type I interferons and pro-inflammatory cytokines to establish an antiviral state [3, 5, 9]. Beyond its role in immunity, the A-form geometry is essential for the mechanism of RNA interference (RNAi), where small interfering RNAs (siRNAs) adopt this conformation to be recognized by the RNA-induced silencing complex (RISC) for targeted gene silencing [8, 18]. Therapeutically, synthetic dsRNA analogues like poly I:C and rintatolimod are utilized as immunomodulators and vaccine adjuvants to enhance anti-tumor and anti-viral responses [3, 5]. However, the clinical application of dsRNA is challenged by significant safety concerns, including the potential for inducing systemic "cytokine storms" and off-target effects [3, 10, 17].
Agonism of pattern recognition receptors (PRRs) such as TLR3, RIG-I, and MDA5 to induce Type I interferons and pro-inflammatory cytokines; serving as a substrate for the RNA-induced silencing complex (RISC) to mediate sequence-specific mRNA degradation.
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on A-form double-stranded RNA (A-form dsRNA).